BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7933812)

  • 41. Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment.
    Ceol M; Nerlich A; Baggio B; Anglani F; Sauer U; Schleicher E; Gambaro G
    Lab Invest; 1996 Feb; 74(2):484-95. PubMed ID: 8780166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal morphologic lesions reminiscent of diabetic nephropathy.
    Raparia K; Usman I; Kanwar YS
    Arch Pathol Lab Med; 2013 Mar; 137(3):351-9. PubMed ID: 23451746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal involvement patterns of amyloid nephropathy: a comparison with diabetic nephropathy.
    Nakamoto Y; Hamanaka S; Akihama T; Miura AB; Uesaka Y
    Clin Nephrol; 1984 Oct; 22(4):188-94. PubMed ID: 6509804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy.
    Makino H; Ikeda S; Haramoto T; Ota Z
    Nephron; 1992; 61(4):415-21. PubMed ID: 1501738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical pathology of the glomerulus--from phenomenon to entity. The nodular-lobular lesion].
    Olsen S
    Verh Dtsch Ges Pathol; 1989; 73():94-104. PubMed ID: 2482639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathology of human diabetic nephropathy.
    Najafian B; Alpers CE; Fogo AB
    Contrib Nephrol; 2011; 170():36-47. PubMed ID: 21659756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nodular glomerulosclerosis of unknown origin associated with the nephrotic syndrome.
    Suzuki S; Maruyama Y; Nakamura T; Ueno M; Nishi S; Ooshima A; Isemura M; Arakawa M
    Nephron; 1994; 66(4):462-9. PubMed ID: 8015653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The nature of basal lamina alterations in human diabetic glomerulosclerosis.
    Huang TW
    Am J Pathol; 1980 Jul; 100(1):225-38. PubMed ID: 7395965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Importance of frequency and morphological characteristics of nodular diabetic glomerulosclerosis in diabetic nephropathy.
    Yasuda F; Mii A; Morita M; Aoki M; Tagawa M; Aratani S; Kaneko T; Sakai Y; Shimizu A
    Hum Pathol; 2018 May; 75():95-103. PubMed ID: 29408640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Collagenofibrotic (Collagen Type III) glomerulopathy in association with diabetic nephropathy.
    Alsaad KO; Edrees B; Rahim KA; Alanazi A; Ahmad M; Aloudah N
    Saudi J Kidney Dis Transpl; 2017; 28(4):898-905. PubMed ID: 28748894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular analysis of glomerular diseases in renal biopsies: initial results of a collaborative international study. The International Study Group for Molecular Study of Kidney Biopsies.
    Esposito C; Striker LJ; Patel A; Peten E; Liu ZH; Sakai H; Striker GE
    Proc Assoc Am Physicians; 1996 May; 108(3):209-17. PubMed ID: 8774054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathologic characteristics of nodular glomerulosclerosis in Chinese patients with type 2 diabetes.
    Zhao HL; Lai FM; Tong PC; Tomlinson B; Chan JC
    Am J Kidney Dis; 2004 Dec; 44(6):1039-49. PubMed ID: 15558525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantification of collagen in renal glomeruli isolated from human nondiabetic and diabetic kidneys.
    Klein L; Butcher DL; Sudilovsky O; Kikkawa R; Miller M
    Diabetes; 1975 Dec; 24(12):1057-65. PubMed ID: 1193310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
    Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of fibrin deposition in diabetic glomerulosclerosis: a light, electron and immunofluorescence microscopy study.
    Farquhar A; MacDonald MK; Ireland JT
    J Clin Pathol; 1972 Aug; 25(8):657-67. PubMed ID: 4561948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy.
    Nishino T; Horii Y; Shiiki H; Yamamoto H; Makita Z; Bucala R; Dohi K
    Hum Pathol; 1995 Mar; 26(3):308-13. PubMed ID: 7890283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SEM studies of acellular glomerular basement membrane in human diabetic glomerulopathy.
    Carlson EC; Surerus KK
    Anat Rec; 1986 Nov; 216(3):349-58. PubMed ID: 3789417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential distribution of type IV collagen chains in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus.
    Yagame M; Kim Y; Zhu D; Suzuki D; Eguchi K; Nomoto Y; Sakai H; Groppoli T; Steffes MW; Mauer SM
    Nephron; 1995; 70(1):42-8. PubMed ID: 7617116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Animal Models of Light Chain Deposition Disease Provide a Better Understanding of Nodular Glomerulosclerosis.
    Herrera GA; Turbat-Herrera EA; Teng J
    Nephron; 2016; 132(2):119-36. PubMed ID: 26794829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.